Big retail, U.S. Congress embrace EPCS in growing push to require E-prescribing for opioids

The national opioid epidemic continues to run rampant, spurring leaders across private and public sectors to take action. Many are embracing electronic prescribing of controlled substances (EPCS) as a critical tool in response to the deepening crisis.
Editor’s Note: This post originally appeared on Imprivata’s website.

Advertisement

Leading private corporations like Walmart and McKesson have helped drive this momentum, each announcing plans involving EPCS. And both federal and state legislatures are matching this push, with a number of different EPCS mandates passed and bills filed recently.

Click here to read more about the effort to combat the opioid crisis.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.